Immunomic TherapeuticsImmunomic Therapeutics
Immunomic TherapeuticsImmunomic Therapeutics
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us

Articles

  • Highlights
  • Events
  • Blog
  • News
  • Articles
  • Press Releases
  • Posters
  • Glioblastoma topples an American hero, but researchers will continue the fight, article by Dr. Duane Mitchell, University of Florida

    Articles Blog
    Senator McCain fought glioblastoma bravely. Our team, and scientists around the world, remain committed to researching treatment options.  Read Dr. Mitchell's article on the progress being made in the treatment
    Read more
  • Raising Awareness for Brain Tumor Research

    Articles Blog Featured
    May is Brain Tumor Awareness Month. In the United States, an estimated 700,000 people are living with a primary brain tumor and 79,000 more will be diagnosed this year. Gliomas
    Read more
  • Biotech Goes to Broadway

    Articles Highlights
    Scientific American’s Custom Media division hosted a unique salon-style event in collaboration with Immunomic Therapeutics on Monday, February 12th in the heart of Manhattan’s Times Square. The forum, Hot Topics in Biotech:
    Read more
  • How Astellas is Working to Change Allergy Prevention through Partnership with Immunomic Therapeutics

    Articles Featured Highlights
    Read how Astellas is working to address a high unmet medical need with first-of-its-kind allergy vaccine development through an innovative partnership. The following article was authored by Astellas and published on
    Read more
  • The Fight Against Cancer Is Increasingly Personal

    Articles Highlights Press
    Scientific American custom media and Immunomic Therapeutics released an article titled, “The Fight Against Cancer is Increasingly Personal,” by reclassifying tumors, scientists are finding a path to genuine cancer cures.
    Read more
  • Md. is developing the next generation of life-saving vaccines

    Articles Blog Press
    Sia Anagnostou, Senior Director at Immunomic Therapeutics authored this article, "Md. is developing the next generation of life-saving vaccines" in the Baltimore Sun. http://www.baltimoresun.com/news/opinion/oped/bs-ed-op-1020-vaccines-md-20171018-story.html  
    Read more
  • What’s Behind the Fear of Vaccines?

    Articles Blog Featured
    A closer look at the social, cultural and political issues influencing immunization This article was produced for Immunomic Therapeutics by Scientific American Custom Media, a division separate from the magazine’s board of editors.
    Read more
  • Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines

    Articles
    May 15, 2017 Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines Immunomic Therapeutics negotiated an exclusive license to Annias Immunotherapeutics’ platform covering technology for targeting cytomegalovirus (CMV) antigens
    Read more
  • William Hearl: ‘If we figure out a way to cure a cancer . . . the money will find us’

    Articles
    William Hearl: ‘If we figure out a way to cure a cancer . . . the money will find us’ William Hearl is founder and chief executive officer of Immunomic
    Read more
  • BioWorld’s PARTNER in FOCUS: Immunomic Therapeutics Inc.

    Articles
    THE REMARKABLE SCIENCE BEHIND LAMP TECHNOLOGY – AND ITS POTENTIAL TO TREAT HUMAN DISEASE http://dev.immunomix.com/old/wp-content/uploads/2016/05/Partner_in_Focus_ITI.pdf The body’s own immune system is its best defense against everything from allergies to cancer –
    Read more
  • The Next Generation of DNA Vaccines Is Poised to Transform the Healthcare Landscape

    Articles
    The Next Generation of DNA Vaccines Is Poised to Transform the Healthcare Landscape By Teri Heiland October 13, 2014 | Contributed Commentary | Over the last several decades, the advent of biotechnology has
    Read more
12
← Previous page

Content
  • Pipeline
  • Partnerships
  • Team
  • Media
  • Contact Us
Careers
  • Careers
  • Compensation & Benefits
  • Culture & Beliefs
Policies
  • Expanded Access Policy
  • Privacy Policy
Social
  • Facebook
  • X / Twitter
  • Youtube
Telephone

+1.301.968.3501

Address

15010 Broschart Road

Rockville, MD 20850

© 2020 Immunomic Therapeutics, Inc. All Rights Reserved.